| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8216569 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 31 Pages |
Abstract
The Amsterdam prognostic model is the first externally validated prognostication tool for OS in ES-NSCLC treated with SABR available to individualize patient decision making. The nomogram retained strong performance across surgical and SABR external validation datasets. RPA performance was poor in surgical patients, suggesting that 2 different distinct patient populations are being treated with these 2 effective modalities.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alexander V. MD, MSc, Cornelis J.A. MD, PhD, Sahar BSc, George B. MD, PhD, Kevin L. MD, Frank J. MD, PhD, David A. MD, PhD, Gregory M.M. MD, CM, Andrew MSc, Johanna J.M. MD, PhD, Chandana A. MS, Alex P.W.M. MD, Neil M. MD, Ben J. MD, PhD, Suresh MRCP,